EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

Documenti analoghi

• EGFR mutation heterogeneity and mixed response to EGFR tyrosine kinase inhibitors of non small cell lung cancer: a clue to overcoming resistance
  di: Remon, Jordi, et al.
  Pubblicazione: (2013)
• Mutation Profile of Resected EGFR‐Mutated Lung Adenocarcinoma by Next‐Generation Sequencing
  di: Zhao, Ze‐Rui, et al.
  Pubblicazione: (2019)
• Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
  di: Marino, Federica Zito, et al.
  Pubblicazione: (2015)
• Correction: Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma
  di: Zito Marino, Federica, et al.
  Pubblicazione: (2015)
• Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas
  di: Cai, Yi-Ran, et al.
  Pubblicazione: (2016)